Hansoh Pharmaceutical jumps most in 8 weeks on Roche tie-up
Tue 03:09
BUZZ-Hansoh Pharmaceutical jumps most in 8 weeks on Roche tie-up ** Shares of Hansoh Pharmaceutical 3692.HK jump 8.3% to HK$34.38, on course for biggest one-day pct gain since August 27
** Stock hits highest level since October 8, up for a third straight session
** China's Hansoh said on Monday it had entered into a partnership and licensing deal with Roche ROPC.S potentially worth more than $15 billion that covers a portfolio of antibody-drug conjugate programmes, which are targeted cancer therapies
** Under the terms of the partnership, Hansoh will lead early development until global Phase Ia clinical trials are complete. Roche will then take over worldwide development and commercialisation
** YTD, stock down 7%, while Hang Seng Biotech Index .HSBIO up 5.6%
(Reporting by Donny Kwok)
Recent news on Roche Holding AG
See all newsNovartis presents weaker-than-expected relapse data for multiple sclerosis drug remibrutinib
Brief: Roche Says Sefaxersen Achieved Statistically Significant 43.1% Reduction In Proteinuria In Interim Phase III Data
Brief: Zymeworks Signs Exclusive Global Licensing Deal With Roche For Cancer Drug ZW209
Zymeworks licenses experimental lung cancer drug to Roche in up to $813 million deal
DB ups Roche to 'buy' on positive oncology survey